Transforming Patient Care Through Innovation
Executive Summary
Is your AI trustworthy? 🤖🔬
A 'scientific content crisis' is leaving 27% of life science professionals unable to trace the data powering their AI. This isn’t just a technical hurdle—it’s a regulatory risk.
Join our upcoming webinar with Fierce Pharma "The Foundation for Trustworthy AI: The FAIR Data Playbook for Pharma," to learn how to move from aspiration to full implementation.
Are you passionate about making life science life changing and delivering impact for patients? We want to hear from you.
About the role:
About us
The Cancer Research UK City of London Centre was established in 2018 as a partnership between University College London, King’s College London, Queen Mary University of London, and The Francis Crick Institute. The Centre’s mission is to foster collaboration between cancer researchers at these four institutions, in order to transform cancer outcomes through effective biological therapies.
We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme.
Discover more about our company wide benefits and life at GSK on our webpage Life at GSK | GSK
Senior Scientist – Translational Science (Immunology)
About Us
The School of Cardiovascular and Metabolic Medicine & Sciences (SCMMS) is one of six schools that make up the Faculty of Life Sciences & Medicine (FoLSM) at King College London. The school drives translation of world-leading basic science into advances in clinical practices with activities focusing on the Cardiac Biomedicine Department of Diabetes and Vascular Biomedicine.
About The Role
Astex Pharmaceuticals is a world leader in innovative drug discovery and development. The company has successfully applied its proprietary Fragment-Based Drug Discovery platform to generate multiple new drug candidates that are progressing in clinical development. Successful collaborations have led to three launched oncology drugs (Kisqali® partnered with Novartis, Balversa® partnered with Janssen and Truqap™ partnered with AstraZeneca). Astex continues to grow and focuses on Neurological Disorders and Oncology.
The Role
Company Overview
BugBiome is developing bioinsecticides derived from the crop microbiome. We isolate and characterise beneficial microbes, screening them for natural insecticidal properties using phenotypic screening of insect behaviour.
Role Summary
Company: Metrion Biosciences
Location: Granta Park, Cambridge, UK
Contract: Permanent, full-time
About Metrion
Metrion Biosciences (‘Metrion’) is a UK-based, ion channel focused Contract Research Organisation (CRO) providing high-quality in vitro preclinical drug discovery and safety profiling services. From our headquarters at Granta Park, Cambridge, we support a global customer base with cardiac safety profiling, ion channel drug discovery screening, medicinal chemistry screening support, and neuroscience assay services.